Timo De Groof

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in 2015. During his master studies, he specialized both in Biomedical Biotechnology and Structural Biology and Biochemistry. During his last year of studies, De Groof performed research in the biopharmaceutical company Argenx and gained experience on the identification and characterization of llama-derived antibodies in inflammatory diseases and oncology.

From 2015 to 2019, De Groof worked as a PhD student in the Medicinal Chemistry group at VU University Amsterdam under the supervision of prof. dr. Martine Smit where he focused on development and characterization of nanobodies targeting viral G protein-coupled receptors while also focusing on different applications of these nanobodies as therapeutics and research tools.

Starting from September 2019, De Groof started working as a postdoctoral researcher in the In Vivo Cellular and Molecular Imaging (ICMI) group under the supervision of prof. dr. Nick Devoogdt. His research focuses on the non-invasive clinical imaging of immune cells using nanobodies (as part of the Horizon 2020 Innovative Medicine Initiative “Immune Image project”).

Starting from November 2022, De Groof has obtained a personal FWO junior postdoctoral grant to further investigate the role of viral G protein-coupled receptors in viral immune evasion in oncology using modulatory nanobodies. 

Timo De Groof studied Biochemistry and Biotechnology at the University of Ghent where he graduated in 2015. During his master studies, he specialized both in Biomedical Biotechnology and Structural Biology and Biochemistry. During his last year of studies, De Groof performed research in the biopharmaceutical company Argenx and gained experience on the identification and characterization of llama-derived antibodies in inflammatory diseases and oncology.

From 2015 to 2019, De Groof worked as a PhD student in the Medicinal Chemistry group at VU University Amsterdam under the supervision of prof. dr. Martine Smit where he focused on development and characterization of nanobodies targeting viral G protein-coupled receptors while also focusing on different applications of these nanobodies as therapeutics and research tools.

Starting from September 2019, De Groof started working as a postdoctoral researcher in the In Vivo Cellular and Molecular Imaging (ICMI) group under the supervision of prof. dr. Nick Devoogdt. His research focuses on the non-invasive clinical imaging of immune cells using nanobodies (as part of the Horizon 2020 Innovative Medicine Initiative “Immune Image project”).

Starting from November 2022, De Groof has obtained a personal FWO junior postdoctoral grant to further investigate the role of viral G protein-coupled receptors in viral immune evasion in oncology using modulatory nanobodies.